The effect of intraperitoneal chemotherapy after interval cytoreductive surgery on recurrence and survival in patients with advanced-stage ovarian carcinoma
Kennard, J.A., Stephens, A.J., Manyam, M., Fitzsimmons, C.K., Kilowski, K.A., DeCoff, K.M., Ahmad, S., Pepe, J.W., McKenzie, N.D., Kendrick, J.E., Holloway, R.W.
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article
Timing of postoperative Foley catheter removal from robotic-assisted radical hysterectomy in patients with early-stage cervical cancer
Fitzsimmons, C.K., Stephens, A.J., Ahmad, S., Pepe, J.W., DeCoff, K.M., Manyam, M., Kennard, J.A., McKenzie, N.D., Holloway, R.W., Kendrick, J.E.
Published in Gynecologic oncology (01.06.2019)
Published in Gynecologic oncology (01.06.2019)
Get full text
Journal Article
837P Phase II trial of oncolytic vaccinia virus primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588)
Holloway, R.W., Mendivil, A.A., Kendrick, J.E., Abaid, L.N., Brown, J.V., Fitzsimmons, C.K., Kennard, J.A., King, M., LeBlanc, J., Lopez, K., Manyam, M., McKenzie, N.D., Mori, K.M., Stephens, A.J., Ahmad, S.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Paraaortic lymph node dissection pathology in patients with endometrial cancer undergoing robotic sentinel lymph node mapping (SLNM)
Kennard, J.A., Stephens, A.J., Ahmad, S., Kendrick, J.E., Gise, J.L., Smith, K.A., McKenzie, N.D., Zhou, X., Holloway, R.W.
Published in Gynecologic oncology (01.06.2018)
Published in Gynecologic oncology (01.06.2018)
Get full text
Journal Article
Recurrence patterns and survival in patients with endometrial cancer undergoing robotic sentinel lymph node mapping (SLNM)
Stephens, A.J., Kennard, J.A., Ahmad, S., Gise, J.L., Smith, K.A., Wisner, K.P.A., Kendrick, J.E., McKenzie, N.D., Pepe, J.W., Holloway, R.W.
Published in Gynecologic oncology (01.06.2018)
Published in Gynecologic oncology (01.06.2018)
Get full text
Journal Article
Phase II VIRO-15 trial of olvimulogene nanivacirepvec (Olvi-Vec)-primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588)
Holloway, R.W., Mendivil, A.A., Kendrick, J.E., Abaid, L.N., Brown, J.V., Fitzsimmons, C.K., Kennard, J.A., King, M.M., LeBlanc, J., Lopez, K., Manyam, M., McKenzie, N.D., Mori, K.M., Smith, J.L., Stephens, A.J., Ahmad, S.
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article